Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentin Goede

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Deutsche Medizinische Wochenschrift (1946)|August 27, 2021
[Malignant Diseases in the Elderly]Valentin Goede, Michael von Bergwelt-Baildon
European Journal of Internal Medicine|December 12, 2018
Management of unfit elderly patients with chronic lymphocytic leukemiaBarbara Eichhorst, Michael Hallek, Valentin Goede
Oncology Research and Treatment|April 17, 2015
Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibodyValentin Goede, Christian Klein, Stephan Stilgenbauer
Leukemia & Lymphoma|February 7, 2009
Treatment of elderly patients with chronic lymphocytic leukemiaBarbara Eichhorst, Valentin Goede, Michael Hallek
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Personalizing therapy for older adults with lymphoid malignancies: options and obstaclesTanya M Wildes, Valentin Goede, Paul Hamlin
Therapeutic Advances in Hematology|June 2, 2017
Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective reviewOthman Al-Sawaf, Paula Cramer, Valentin Goede, et al.
Leukemia & Lymphoma|September 16, 2014
Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemiaValentin Goede, Barbara Eichhorst, Kirsten Fischer, et al.
The Lancet. Haematology|October 8, 2021
A comprehensive approach to therapy of haematological malignancies in older patientsRaul Cordoba, Toby A Eyre, Heidi D Klepin, et al.
Drug Design, Development and Therapy|February 10, 2017
Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapyOthman Al-Sawaf, Kirsten Fischer, Anja Engelke, et al.
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Deutsche Medizinische Wochenschrift (1946)|August 27, 2021
[Malignant Diseases in the Elderly]Valentin Goede, Michael von Bergwelt-Baildon
European Journal of Internal Medicine|December 12, 2018
Management of unfit elderly patients with chronic lymphocytic leukemiaBarbara Eichhorst, Michael Hallek, Valentin Goede
Oncology Research and Treatment|April 17, 2015
Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibodyValentin Goede, Christian Klein, Stephan Stilgenbauer
Leukemia & Lymphoma|February 7, 2009
Treatment of elderly patients with chronic lymphocytic leukemiaBarbara Eichhorst, Valentin Goede, Michael Hallek
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Personalizing therapy for older adults with lymphoid malignancies: options and obstaclesTanya M Wildes, Valentin Goede, Paul Hamlin
Therapeutic Advances in Hematology|June 2, 2017
Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective reviewOthman Al-Sawaf, Paula Cramer, Valentin Goede, et al.
Leukemia & Lymphoma|September 16, 2014
Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemiaValentin Goede, Barbara Eichhorst, Kirsten Fischer, et al.
The Lancet. Haematology|October 8, 2021
A comprehensive approach to therapy of haematological malignancies in older patientsRaul Cordoba, Toby A Eyre, Heidi D Klepin, et al.
Drug Design, Development and Therapy|February 10, 2017
Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapyOthman Al-Sawaf, Kirsten Fischer, Anja Engelke, et al.
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Pageof 6